Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Philadelphia Chromosome × nilotinib × Clear all

Phase

Phase 3 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Leukemia 4 Leukemia, Myeloid, Chronic-Phase 2 Blast Crisis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Piebaldism 1 Philadelphia Chromosome 1 Myeloproliferative Disorders 1 Gastrointestinal Stromal Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01061177 2017-02-24

'MACS1252

Novartis

Phase 4 Completed

1,090 enrolled 24 charts

Other hematologic neoplasm

Leukemia, Philadelphia Chromosome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡